Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RPRX
#573
Royalty Pharma plc Class A Ordinary Shares
48.820
0
USD
+0.81%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.81%
Aylık Değişim
+6.52%
6 aylık değişim
+31.03%
Yıllık Değişim
+31.03%
Önceki Kapanış
48.430
0
Open
48.820
0
Bid
Ask
Low
48.820
0
High
48.820
0
Hacim
203
Piyasalar
ABD Borsası
Sağlık Hizmetleri
RPRX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
—
Valuation ratios
Enterprise value
29.42 B
27.35 B
25.83 B
21.89 B
20.17 B
27.82 B
100.77 B
Price to earnings ratio
31.16
39.04
394
11.17
13.36
21.71
70.31
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
34.98
Price to cash flow ratio
9.24
8.19
8.05
5.7
5.47
8.76
32.76
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
5.6
Enterprise value to EBITDA ratio
168.52 K
113.31 K
577.4 K
109.36 K
120.6 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0.04
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0.08
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
34.06
34.9
Gross margin %
92.64
100.56
68.24
75.24
63.21
111.34
447.42
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
262.81
EBITDA margin %
84.97
93.29
18.52
65.6
53.88
62.24
248.14
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
0.13
Solvency ratios
Debt to assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Debt to equity ratio
1.21
1.23
1.09
0.94
0.95
1.33
4.76
Long term debt to total assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Long term debt to total equity ratio
1.21
1.23
1.09
0.94
0.95
1.32
4.75
Per share metrics
Operating cash flow per share
3.35
3.32
4.9
4.96
4.66
4.41
4.4
EBIT per share
2.63
2.36
0.7
2.47
2.18
2.76
2.75
EBITDA per share
2.97
3.52
0.95
2.56
2.05
2.62
2.63
Total debt per share
9.58
11.69
13.97
10.18
11.13
15.22
54.5
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
5.89
Net current asset value per share
4.44
4.74
5.83
2.11
3.03
2.71
11.9
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
40.86
Working capital per share
3.94
4.46
3.17
1.85
0.92
1.58
5.64
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
45.8
Haberler
Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)
Leerink, olumlu deneme verileri sonrası Spyre hisse notunu korudu
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Royalty Pharma hissesi 47,87 dolarla 52 haftanın zirvesinde
TD Cowen, Royalty Pharma için Al tavsiyesini korudu
Royalty Pharma, J&J’nin otoimmün ilaç geliştirmesine 500 milyon dolar ayırdı
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?
Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
Royalty Pharma yapay zeka başkanı olarak Lucas Glass’ı atadı
Royalty Pharma, Greg Butz’u ortak ve yatırım başkanı atadı